The affirmation of the rating was based on Parkview’s strong balance sheet, good market position, conservative asset liability management policies and good debt measures.
Parkview’s market share of inpatient admissions is approximately 67 percent. In addition, the hospital’s balance sheet measures are strong and improving, with 285 days cash on hand as of June 30.
The maintenance of the stable outlook is based on the expectation Parkview will continue to hold its market position and maintain current levels of profitability.
More articles on hospital credit ratings:
Moody’s affirms Saint Mary’s Hospital’s ‘Ba2’ rating
Fitch affirms “A+” Gunderson Lutheran bond rating
Moody’s affirms UW Hospital and Clinics’ “Aa3” rating
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
